摘要
医药产业属于高技术型的产业,其技术的核心要素——专利不仅是技术保护手段,更是有力的竞争手段,由此带来的专利风险也日益显现。目前风险管理理论在全球各个行业比较盛行,但是我国的医药企业在风险管理上还很缺乏认知性,本文从风险管理理论角度对我国医药企业的专利风险因素进行分析,为我国医药企业日后的风险衡量和评估提供依据,并且在此基础上可以进行有针对性的风险防范和控制。
The pharmaceutical industry is a high-tech industry; its core technical element is patent, which is not only a technical protection measure but also a stron creasing. The risk management theory is very popular in g th competitive mean. Thus the resultant patent risk is in- e world; however, Chinese pharmaceutical enterprises have not yet pay more attention to this theory. This article analyzed all the main patent risk factors of Chinese phar- maceutical industries on the basis of the risk management theory. The conclusion will provide a basis of risk meas- urement and evaluation in the future, and a basis for the enterprises to arrange the targeted prevention and control- ling of the patent risk accordingly
出处
《中国新药杂志》
CAS
CSCD
北大核心
2012年第23期2727-2730,共4页
Chinese Journal of New Drugs
关键词
医药企业
专利
风险因素
分析
pharmaceutical enterprises
patent
risk factors
analysis